SULPHASALAZINE RETENTION ENEMAS IN ULCERATIVE-COLITIS - A DOUBLE-BLIND TRIAL

[1] AZADKHAN AK, 1977, LANCET, V2, P892

[2] BARON JH, 1962, LANCET, V1, P1094

[3] ADVERSE REACTIONS DURING SALICYLAZOSULFAPYRIDINE THERAPY AND RELATION WITH DRUG-METABOLISM AND ACETYLATOR PHENOTYPE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (10) : 491 - 495

[4] FRIMBERGER E, 1980, MUNCHEN MED WOCHEN, V122, P1233

[5] FRUHMORGEN P, 1980, HEPATO-GASTROENTEROL, V27, P473

[6] SULPHASALAZINE DESENSITIZATION [J]. BRITISH MEDICAL JOURNAL, 1981, 282 (6258) : 110 - 110

[7] MISIEWICZ JJ, 1965, LANCET, V1, P185

[8] SCHRODER H, 1972, CLIN PHARMACOL THER, V13, P539

[9] EFFECT OF SULFAPYRIDINE, 5-AMINOSALICYLIC ACID, AND PLACEBO IN PATIENTS WITH IDIOPATHIC PROCTITIS - A STUDY TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE [J]. GUT, 1980, 21 (07) : 632 - 635

[10] WATKINSON G, 1968, ULCERATIVE COLITIS, P207

[1] AZADKHAN AK, 1977, LANCET, V2, P892

[2] BARON JH, 1962, LANCET, V1, P1094

[3] ADVERSE REACTIONS DURING SALICYLAZOSULFAPYRIDINE THERAPY AND RELATION WITH DRUG-METABOLISM AND ACETYLATOR PHENOTYPE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (10) : 491 - 495

[4] FRIMBERGER E, 1980, MUNCHEN MED WOCHEN, V122, P1233

[5] FRUHMORGEN P, 1980, HEPATO-GASTROENTEROL, V27, P473

[6] SULPHASALAZINE DESENSITIZATION [J]. BRITISH MEDICAL JOURNAL, 1981, 282 (6258) : 110 - 110

[7] MISIEWICZ JJ, 1965, LANCET, V1, P185

[8] SCHRODER H, 1972, CLIN PHARMACOL THER, V13, P539

[9] EFFECT OF SULFAPYRIDINE, 5-AMINOSALICYLIC ACID, AND PLACEBO IN PATIENTS WITH IDIOPATHIC PROCTITIS - A STUDY TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE [J]. GUT, 1980, 21 (07) : 632 - 635

[10] WATKINSON G, 1968, ULCERATIVE COLITIS, P207